Abstract
Asthma is the most prevalent chronic respiratory disease, affecting more than 300 million people worldwide1 . Although asthma is a heterogenous disease that presents with various phenotypes, around 50 % of the patients suffer from type 2 inflammation, characterized by elevated levels of IgE, type 2 cytokines such as IL-4 and IL-13 and eosinophilia1 .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
